Biolidics Ltd
SGX:8YY
Biolidics Ltd
SGX:8YY
Price:
0.045
SGD
-10%
Market Closed
Market Cap:
S$78m
Income Statement
Earnings Waterfall
Biolidics Ltd
Biolidics Ltd
Income Statement
Biolidics Ltd
Biolidics Ltd
Currency: SGD
| Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Interest Expense |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
1
N/A
|
2
+29%
|
1
-12%
|
8
+424%
|
9
+18%
|
2
-73%
|
2
-5%
|
2
+2%
|
3
+32%
|
2
-20%
|
4
+44%
|
3
-16%
|
2
-24%
|
0
-88%
|
0
-3%
|
0
-35%
|
0
-15%
|
1
+423%
|
|
| Gross Profit | |||||||||||||||||||
| Cost of Revenue |
(0)
|
(0)
|
(0)
|
(4)
|
(5)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
|
| Gross Profit |
1
N/A
|
1
+32%
|
1
-17%
|
3
+244%
|
3
+3%
|
0
-93%
|
0
+106%
|
1
+64%
|
1
+49%
|
1
-2%
|
2
+50%
|
2
-7%
|
1
-23%
|
0
-88%
|
0
+8%
|
0
-35%
|
0
-23%
|
0
+137%
|
|
| Operating Income | |||||||||||||||||||
| Operating Expenses |
(6)
|
(6)
|
(6)
|
(6)
|
(9)
|
(8)
|
(6)
|
(6)
|
(7)
|
(11)
|
(12)
|
(10)
|
(9)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(2)
|
(1)
|
(3)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
|
| Research & Development |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
(3)
|
(3)
|
(2)
|
(3)
|
(4)
|
(3)
|
(2)
|
(2)
|
(2)
|
(7)
|
(7)
|
(7)
|
(7)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Operating Income |
(5)
N/A
|
(5)
-1%
|
(5)
+10%
|
(3)
+33%
|
(5)
-65%
|
(7)
-44%
|
(6)
+21%
|
(5)
+10%
|
(6)
-17%
|
(10)
-59%
|
(10)
-3%
|
(8)
+17%
|
(8)
+4%
|
(1)
+82%
|
(2)
-52%
|
(2)
+1%
|
(2)
+8%
|
(3)
-51%
|
|
| Pre-Tax Income | |||||||||||||||||||
| Interest Income Expense |
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
(0)
|
0
|
(0)
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(6)
N/A
|
(5)
+16%
|
(5)
+8%
|
(3)
+34%
|
(5)
-48%
|
(8)
-62%
|
(6)
+21%
|
(5)
+12%
|
(6)
-17%
|
(10)
-59%
|
(10)
-3%
|
(8)
+17%
|
(8)
+3%
|
(2)
+82%
|
(2)
-45%
|
(2)
+2%
|
(2)
+8%
|
(3)
-61%
|
|
| Net Income | |||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Income from Continuing Operations |
(6)
|
(5)
|
(5)
|
(3)
|
(5)
|
(8)
|
(6)
|
(5)
|
(6)
|
(9)
|
(10)
|
(8)
|
(8)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
|
| Net Income (Common) |
(6)
N/A
|
(5)
+16%
|
(5)
+8%
|
(3)
+34%
|
(5)
-47%
|
(8)
-62%
|
(6)
+21%
|
(5)
+12%
|
(6)
-17%
|
(9)
-53%
|
(10)
-4%
|
(8)
+17%
|
(8)
+3%
|
(2)
+68%
|
(3)
-17%
|
(3)
-3%
|
(3)
+6%
|
(3)
-22%
|
|
| EPS (Diluted) |
-0.05
N/A
|
-0.02
+60%
|
-0.02
N/A
|
-0.01
+50%
|
-0.02
-100%
|
-0.03
-50%
|
-0.02
+33%
|
-0.02
N/A
|
-0.02
N/A
|
-0.03
-50%
|
-0.03
N/A
|
-0.03
N/A
|
-0.02
+33%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
